PAPER Nelson RB, Rose KN, Menniti FS, Zorn SH
SEARCH RESULTS
18688 RESULTS
PAPER Wang Z, Wang R, Niu L, Zhou X, Han J, Li K
EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance.
NPJ Aging. 2024 May 4;10(1):24. PubMed.PAPER Vaidya B, Gupta P, Biswas S, Laha JK, Roy I, Sharma SS
Effect of Clemizole on Alpha-Synuclein-Preformed Fibrils-Induced Parkinson's Disease Pathology: A Pharmacological Investigation.
Neuromolecular Med. 2024 May 4;26(1):19. PubMed.PAPER De Kort AM, Kaushik K, Kuiperij HB, Jäkel L, Li H, Tuladhar AM, Terwindt GM, Wermer MJ, Claassen JA, Klijn CJ, Verbeek MM, Kessels RP, Schreuder FH
The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy.
Alzheimers Res Ther. 2024 May 4;16(1):99. PubMed.PAPER Koemans E, Perosa V, Freeze W, Lee H, Kozberg MG, Coughlan GT, Buckley RF, Wermer M, Greenberg SM, van Veluw SJ
Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhage.
Int J Stroke. 2024 May 4;:17474930241255276. PubMed.PAPER Lu J, Zhang J, Wang X, Yuan F, Xin B, Li J, Yang Q, Li X, Zhang J, Wang X, Fu J, Guo C
Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice.
Brain Res Bull. 2024 May 3;:110969. PubMed.PAPER Chen Y, Zhang W, Li Q, Xie H, Xing S, Lu X, Lyu W, Xiong B, Wang Y, Qu W, Liu W, Chi H, Zhang X, Feng F, Sun H
Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease.
Eur J Med Chem. 2024 Apr 30;272:116463. PubMed.PAPER Ashendorf L, Withrow S, Gavett BE
The Neuropsychological Assessment Battery Driving Scenes Test in a Dementia Clinic.
Arch Clin Neuropsychol. 2024 May 4; PubMed.PAPER Conca F, Esposito V, Catricalà E, Manenti R, L'Abbate F, Quaranta D, Giuffrè GM, Rossetto F, Solca F, Orso B, Inguscio E, Crepaldi V, De Matteis M, Rotondo E, Manera M, Caruso G, Catania V, Canu E, Rundo F, Cotta Ramusino M, Filippi M, Fundarò C, Piras F, Arighi A, Tiraboschi P, Stanzani Maserati M, Pardini M, Poletti B, Silani V, Marra C, Di Tella S, Cotelli M, Lodi R, Tagliavini F, Cappa SF
Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease.
Alzheimers Res Ther. 2024 May 4;16(1):98. PubMed.PAPER Sanchez-Rodriguez LM, Bezgin G, Carbonell F, Therriault J, Fernandez-Arias J, Servaes S, Rahmouni N, Tissot C, Stevenson J, Karikari TK, Ashton NJ, Benedet AL, Zetterberg H, Blennow K, Triana-Baltzer G, Kolb HC, Rosa-Neto P, Iturria-Medina Y
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease.
Commun Biol. 2024 May 4;7(1):528. PubMed.PAPER Sunwoo Y, Park J, Choi CY, Shin S, Choi YJ
Risk of dementia and Alzheimer's disease associated with antidiabetics: A Bayesian network meta-analysis.
Am J Prev Med. 2024 May 3; PubMed.PAPER Haidar M, Schmid B, Ruiz A, Ebneth A, Cabrera-Socorro A
Generation of three isogenic, gene-edited iPSC lines carrying the APOE-Christchurch mutation into the three common APOE variants: APOE2Ch, APOE3Ch and APOE4Ch.
Stem Cell Res. 2024 Apr 6;77:103414. PubMed.PAPER Thumbadoo KM, Dieriks BV, Murray HC, Swanson ME, Yoo JH, Mehrabi NF, Turner C, Dragunow M, Faull RL, Curtis MA, Siddique T, Shaw CE, Newell KL, Henden L, Williams KL, Nicholson GA, Scotter EL
Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.
Brain. 2024 May 4; PubMed.PAPER Chen Y, Xu R, Liu Q, Zeng Y, Chen W, Liu Y, Cao Y, Liu G, Chen Y
Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans models.
Mol Neurobiol. 2024 May 4; PubMed.PAPER Wang M, Lu J, Zhang Y, Zhang Q, Wang L, Wu P, Brendel M, Rominger A, Shi K, Zhao Q, Jiang J, Zuo C